Delivery Order SPE2DB22D2006-SPE2DB25FV8JW

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,977.56 Firm Fixed Price delivery order is for the supply of LIDOCAINE HCL 4% SOLUTION 50ML, a medical product. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DX15D3026|SPE2DX24FUWZB, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.91 firm fixed-price delivery order is for the supply of 4564793765 - LIDOCAINE HCL 2% LUER-JET 5ML, a medical product. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.14, is for the delivery of 4566422986 - LIDOCAINE 2% VISCOUS SOLN 100ML, with a completion date of November 14, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $2,997.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was made to Amerisourcebergen Drug Corp, Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,533.00, is a Delivery Order with a Firm Fixed Price awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract is for the delivery of 4564381288 - LIDOCAINE HCL 2% VIAL 5ML, with a performance period ending on April 25, 2024. This award is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,647.10, is a Firm Fixed Price Delivery Order for the supply of LIDOCAINE HCL 1% 50 MG/5 ML VL 5ML, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award is for the delivery of Lidocaine HCL 1% ampules to the Defense Logistics Agency (DLA). The $1,224.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,731.76 firm-fixed-price delivery order is for the supply of 4560703404 - Lidocaine HCL 1% Vial 2ML, with a period of performance through April 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award, valued at $6,379.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 2% 200 MG/10 ML 10ML, a medical product. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,888.91 firm fixed-price contract is for the supply of 4563714161 LIDOCAINE HCL 2% 200 MG/10 ML 10ML, a medical product. The contract has a period of performance through February 21, 2024. AmerisourceBergen is an experienced federal contractor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8JW
    Delivery Order

This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV8JW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,120.98 firm-fixed-price delivery order is for the supply of 4567268890 ! LIDOCAINE HCL 1% VIAL 10ML and has a completion date of February 14, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/22/25, 8:36 PM